Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FYP46
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,569
Award facts
- Contract value 100% obligated
- $24,568.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $24,568.74 by the Defense Logistics Agency (DLA) on July 7, 2025, for the supply of Keytruda 100 mg/4 ml vials. This delivery order, with an ultimate completion date of July 28, 2025, carries no set-aside designation and represents a specific purchase requisition under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The product will be delivered to Park Ridge, Illinois, and is intended to support the pharmaceutical supply needs of Department of Defense healthcare facilities.
This award is issued under DMS Pharmaceutical Group's single-award IDC with the DLA valued at approximately $500 million and valid through November 2026. The IDC enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables. As a primary supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently secured contracts with the DLA to distribute medications and medical supplies to military health facilities nationwide, establishing the company as a critical vendor for Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FYP46?
SPE2DB25FYP46 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 7, 2025.
How much is contract SPE2DB25FYP46 worth?
The government has obligated $24,569 on SPE2DB25FYP46.
Is contract SPE2DB25FYP46 an order under another contract?
Yes. SPE2DB25FYP46 is a delivery order under SPE2DB22D9316, an indefinite delivery contract.
Was contract SPE2DB25FYP46 competed?
The extent of competition for SPE2DB25FYP46 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award